Sonida Senior Living, Inc. (SNDA)
NYSE: SNDA · Real-Time Price · USD
25.98
+0.48 (1.88%)
At close: Aug 13, 2025, 4:00 PM
25.98
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
Sonida Senior Living Market Cap
Sonida Senior Living has a market cap or net worth of $465.14 million as of August 13, 2025. Its market cap has increased by 6.00% in one year.
Market Cap
465.14M
Enterprise Value
1.13B
1-Year Change
6.00%
Ranking
Category
Stock Price
$25.98
Market Cap Chart
Since December 1, 1998, Sonida Senior Living's market cap has increased from $246.50M to $465.14M, an increase of 88.70%. That is a compound annual growth rate of 2.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 464.20M | 5.48% |
| Dec 31, 2024 | 440.10M | 457.09% |
| Dec 29, 2023 | 79.00M | -5.28% |
| Dec 30, 2022 | 83.40M | -54.58% |
| Dec 31, 2021 | 183.60M | 598.10% |
| Dec 31, 2020 | 26.30M | -72.94% |
| Dec 31, 2019 | 97.20M | -54.30% |
| Dec 31, 2018 | 212.70M | -48.26% |
| Dec 29, 2017 | 411.10M | -14.59% |
| Dec 30, 2016 | 481.30M | -21.84% |
| Dec 31, 2015 | 615.80M | -15.03% |
| Dec 31, 2014 | 724.70M | 4.88% |
| Dec 31, 2013 | 691.00M | 31.14% |
| Dec 31, 2012 | 526.90M | 139.72% |
| Dec 30, 2011 | 219.80M | 21.17% |
| Dec 31, 2010 | 181.40M | 32.70% |
| Dec 31, 2009 | 136.70M | 71.95% |
| Dec 31, 2008 | 79.50M | -69.87% |
| Dec 31, 2007 | 263.90M | -5.99% |
| Dec 29, 2006 | 280.70M | 3.50% |
| Dec 30, 2005 | 271.20M | 86.14% |
| Dec 31, 2004 | 145.70M | 25.06% |
| Dec 31, 2003 | 116.50M | 131.61% |
| Dec 31, 2002 | 50.30M | -14.16% |
| Dec 31, 2001 | 58.60M | 21.83% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |